621 related articles for article (PubMed ID: 9092853)
21. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
22. Gene Therapy in the Nervous System: Failures and Successes.
Chandran JS; Scarrott JM; Shaw PJ; Azzouz M
Adv Exp Med Biol; 2017; 1007():241-257. PubMed ID: 28840561
[TBL] [Abstract][Full Text] [Related]
23. Gene delivery with viral vectors for cerebrovascular diseases.
Gan Y; Jing Z; Stetler RA; Cao G
Front Biosci (Elite Ed); 2013 Jan; 5(1):188-203. PubMed ID: 23276981
[TBL] [Abstract][Full Text] [Related]
24. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
25. Strategies for the development of cell lines for ex vivo gene therapy in the central nervous system.
Mejía-Toiber J; Castillo CG; Giordano M
Cell Transplant; 2011; 20(7):983-1001. PubMed ID: 21176399
[TBL] [Abstract][Full Text] [Related]
26. Immortalized neural progenitor cells for CNS gene transfer and repair.
Martínez-Serrano A; Björklund A
Trends Neurosci; 1997 Nov; 20(11):530-8. PubMed ID: 9364668
[TBL] [Abstract][Full Text] [Related]
27. [Outlook for the use of nerve tissue xenotransplantation in neurosurgery].
Savel'ev SV
Arkh Patol; 1995; 57(2):11-8. PubMed ID: 7611889
[TBL] [Abstract][Full Text] [Related]
28. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
29. Use of gene therapy in central nervous system repair.
Tinsley R; Eriksson P
Acta Neurol Scand; 2004 Jan; 109(1):1-8. PubMed ID: 14653844
[TBL] [Abstract][Full Text] [Related]
30. Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer.
Sevenich L
Front Immunol; 2018; 9():697. PubMed ID: 29681904
[TBL] [Abstract][Full Text] [Related]
31. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
32. Immunology and immunotherapy in neurosurgical disease.
Prins RM; Liau LM
Neurosurgery; 2003 Jul; 53(1):144-52; discussion 152-3. PubMed ID: 12823883
[TBL] [Abstract][Full Text] [Related]
33. Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.
de Silva S; Bowers WJ
Curr Gene Ther; 2011 Oct; 11(5):332-40. PubMed ID: 21711226
[TBL] [Abstract][Full Text] [Related]
34. [Neurosurgery in the 21st century--development of stereotactic and functional neurosurgery].
Itakura T
No Shinkei Geka; 2002 Apr; 30(4):351-6. PubMed ID: 11968821
[No Abstract] [Full Text] [Related]
35. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer for cerebrovascular disease.
Khurana VG; Katusic ZS
Curr Cardiol Rep; 2001 Jan; 3(1):10-6. PubMed ID: 11139793
[TBL] [Abstract][Full Text] [Related]
37. Cell replacement therapies for central nervous system disorders.
Björklund A; Lindvall O
Nat Neurosci; 2000 Jun; 3(6):537-44. PubMed ID: 10816308
[TBL] [Abstract][Full Text] [Related]
38. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.
Corti O; Sabaté O; Horellou P; Colin P; Dumas S; Buchet D; Buc-Caron MH; Mallet J
Nat Biotechnol; 1999 Apr; 17(4):349-54. PubMed ID: 10207882
[TBL] [Abstract][Full Text] [Related]
39. Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions.
Uchitel J; Kantor B; Smith EC; Mikati MA
Pediatr Neurol; 2020 Sep; 110():5-19. PubMed ID: 32684374
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for the nervous system: challenges and new strategies.
Maguire CA; Ramirez SH; Merkel SF; Sena-Esteves M; Breakefield XO
Neurotherapeutics; 2014 Oct; 11(4):817-39. PubMed ID: 25159276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
